Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enrico Lucarelli

Showing results (21-30 of 81) with videos related to

Pageof 9
Sort By:
Iscience|September 17, 2024
Feasibility and barriers to rapid establishment of patient-derived primary osteosarcoma cell lines in clinical managementThomas Chow, William Humble, Enrico Lucarelli, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|November 8, 2011
Cell growth inhibition and apoptotic effect of the rexinoid 6-OH-11-O-hydroxyphenantrene on human osteosarcoma and mesenchymal stem cellsBarbara Dozza, Alessio Papi, Enrico Lucarelli, et al.
Journal of Biomedical Materials Research. Part B, Applied Biomaterials|May 9, 2015
Characterization and cytocompatibility of a new injectable multiphasic bone substitute based on a combination of polysaccharide gel-coated OSPROLIFE(®) HA/TTCP granules and bone marrow concentrateMichela Pierini, Enrico Lucarelli, Serena Duchi, et al.
Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons|January 14, 2009
Effect of mesenchymal stem cells and platelet-rich plasma on the healing of standardized bone defects in the alveolar ridge: a comparative histomorphometric study in minipigsFrancesco Pieri, Enrico Lucarelli, Giuseppe Corinaldesi, et al.
Extracellular Vesicles and Circulating Nucleic Acids|October 24, 2025
Meeting abstracts of the GISM Annual Meeting 2025Enrico Ragni, Enrico Lucarelli, Stefano Grolli, et al.
Journal of Tissue Engineering and Regenerative Medicine|July 28, 2021
Minimally invasive treatment of long bone non-unions with bone marrow concentrate, demineralized bone matrix and platelet-rich fibrin in 38 patientsLuca Cevolani, Giuseppe Bianchi, Errani Costantino, et al.
Frontiers in Bioengineering and Biotechnology|October 30, 2020
Innovative Options for Bone Metastasis Treatment: An Extensive Analysis on Biomaterials-Based Strategies for Orthopedic SurgeonsAnia Naila Guerrieri, Monica Montesi, Simone Sprio, et al.
Stem Cells and Development|December 18, 2014
Ex vivo expanded mesenchymal stromal cell minimal quality requirements for clinical applicationMaria Luisa Torre, Enrico Lucarelli, Simona Guidi, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|February 2, 2011
Mesenchymal stem cells and platelet lysate in fibrin or collagen scaffold promote non-cemented hip prosthesis integrationBarbara Dozza, Claudia Di Bella, Enrico Lucarelli, et al.
Cancer Letters|November 1, 2015
A novel antagonist of CXCR4 prevents bone marrow-derived mesenchymal stem cell-mediated osteosarcoma and hepatocellular carcinoma cell migration and invasionRaffaela Fontanella, Alessandra Pelagalli, Anna Nardelli, et al.
Pageof 9

Showing results (21-30 of 81) with videos related to

Sort By:
Pageof 9
Iscience|September 17, 2024
Feasibility and barriers to rapid establishment of patient-derived primary osteosarcoma cell lines in clinical managementThomas Chow, William Humble, Enrico Lucarelli, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|November 8, 2011
Cell growth inhibition and apoptotic effect of the rexinoid 6-OH-11-O-hydroxyphenantrene on human osteosarcoma and mesenchymal stem cellsBarbara Dozza, Alessio Papi, Enrico Lucarelli, et al.
Journal of Biomedical Materials Research. Part B, Applied Biomaterials|May 9, 2015
Characterization and cytocompatibility of a new injectable multiphasic bone substitute based on a combination of polysaccharide gel-coated OSPROLIFE(®) HA/TTCP granules and bone marrow concentrateMichela Pierini, Enrico Lucarelli, Serena Duchi, et al.
Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons|January 14, 2009
Effect of mesenchymal stem cells and platelet-rich plasma on the healing of standardized bone defects in the alveolar ridge: a comparative histomorphometric study in minipigsFrancesco Pieri, Enrico Lucarelli, Giuseppe Corinaldesi, et al.
Extracellular Vesicles and Circulating Nucleic Acids|October 24, 2025
Meeting abstracts of the GISM Annual Meeting 2025Enrico Ragni, Enrico Lucarelli, Stefano Grolli, et al.
Journal of Tissue Engineering and Regenerative Medicine|July 28, 2021
Minimally invasive treatment of long bone non-unions with bone marrow concentrate, demineralized bone matrix and platelet-rich fibrin in 38 patientsLuca Cevolani, Giuseppe Bianchi, Errani Costantino, et al.
Frontiers in Bioengineering and Biotechnology|October 30, 2020
Innovative Options for Bone Metastasis Treatment: An Extensive Analysis on Biomaterials-Based Strategies for Orthopedic SurgeonsAnia Naila Guerrieri, Monica Montesi, Simone Sprio, et al.
Stem Cells and Development|December 18, 2014
Ex vivo expanded mesenchymal stromal cell minimal quality requirements for clinical applicationMaria Luisa Torre, Enrico Lucarelli, Simona Guidi, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|February 2, 2011
Mesenchymal stem cells and platelet lysate in fibrin or collagen scaffold promote non-cemented hip prosthesis integrationBarbara Dozza, Claudia Di Bella, Enrico Lucarelli, et al.
Cancer Letters|November 1, 2015
A novel antagonist of CXCR4 prevents bone marrow-derived mesenchymal stem cell-mediated osteosarcoma and hepatocellular carcinoma cell migration and invasionRaffaela Fontanella, Alessandra Pelagalli, Anna Nardelli, et al.
Pageof 9